PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.34%
Revenue growth at 50-75% of NXPI's 3.21%. Martin Whitman would worry about competitiveness or product relevance.
1.44%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
10.06%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
9.27%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
-7.68%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-3.85%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-4.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-5.29%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.04%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
8.69%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-58.68%
Negative OCF growth while NXPI is at 37.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-152.53%
Negative FCF growth while NXPI is at 94.26%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
43.68%
10Y revenue/share CAGR at 50-75% of NXPI's 79.10%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-12.20%
Negative 5Y CAGR while NXPI stands at 77.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
14.04%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
322.80%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
57.02%
5Y OCF/share CAGR at 50-75% of NXPI's 107.18%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
29.13%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
2488.56%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
66.59%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
205.05%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
261.53%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
211.41%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
147.24%
3Y equity/share CAGR above 1.5x NXPI's 42.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
16.57%
Dividend/share CAGR of 16.57% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
38.50%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
2.24%
Below 50% of NXPI's 20.43%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
0.10%
AR growth is negative/stable vs. NXPI's 1.04%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.81%
Inventory growth well above NXPI's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
16.45%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
27.76%
BV/share growth above 1.5x NXPI's 3.20%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.41%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
18.99%
R&D growth drastically higher vs. NXPI's 4.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-18.83%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.